Skip to main content

Table 2 Methylation levels of four CpG sites in C3 promoter between CAD and controls

From: A preliminary study showing no association between methylation levels of C3 gene promoter and the risk of CAD

CpG site CAD (%) Control (%) P P a
1 56.1 ± 6.7 54.5 ± 8.3 0.124 0.123
2 57.3 ± 6.8 55.9 ± 8.0 0.195 0.174
3 61.1 ± 6.6 59.8 ± 7.5 0.180 0.175
4 59.6 ± 6.8 58.6 ± 7.8 0.192 0.169
Average 58.5 ± 6.6 57.1 ± 7.8 0.165 0.153
  1. C3 component 3, CAD coronary artery disease, Pa adjustment for EH, DM, and smoking status